SOLIGENIX, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.740 USD | -9.88% |
|
+6.86% | -69.13% |
| Aug. 18 | Transcript : Soligenix, Inc. - Special Call | |
| Aug. 09 | Soligenix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 | CI |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Public Health Solutions | 3.4M | 2.24M | 824K | 917K | 444K | |||||
Total Assets | 1.02M | 176K | 146K | 121K | 3.98K | |||||
D&A | 17.51K | 21.67K | 16.8K | 1.68K | 655 | |||||
Operating Income | 154K | -435K | -648K | 26.61K | -36.53K | |||||
Biological Products | ||||||||||
Specialized Biotherapeutics | 1.23M | 117K | - | 31.93K | 395K | |||||
Total Assets | 41.7K | 148K | 129K | 104K | 272K | |||||
D&A | 18.12K | 11.84K | 7.8K | 10.09K | 3.93K | |||||
Operating Income | -6.74M | -13.61M | -7.28M | -7.61M | -2.81M | |||||
Total Assets | 6.71M | 19.57M | 26.59M | 14.05M | 9.52M | |||||
D&A | 18.82K | 28.86K | 9.56K | 12.79K | 1.97K | |||||
Operating Income | -3.96M | -4.54M | -5.21M | -6.65M | -4.85M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 4.63M | 2.36M | 824K | 949K | 839K | |||||
Total Assets | 7.78M | 19.89M | 26.87M | 14.28M | 9.8M | |||||
Interest Expense | - | -10.88K | -863K | -823K | -49.13K | |||||
Income Tax Expense | -611K | -837K | -865K | -1.15M | -1.77M | |||||
D&A | 46.7K | 178K | 135K | 130K | 118K | |||||
CAPEX | -30.21K | -7.15K | -11.79K | -13.07K | - | |||||
Gross Profit | 1.06M | 538K | 95.63K | 398K | 97.31K | |||||
Net Income | -9.36M | -17.69M | -12.55M | -13.8M | -6.14M | |||||
EBT | -9.97M | -18.53M | -13.42M | -14.95M | -7.91M | |||||
Operating Income | -10.54M | -18.59M | -13.14M | -14.24M | -7.7M |
- Stock Market
- Equities
- SNGX Stock
- Financials Soligenix, Inc.
- Business Segments